Poly-Gamma-Glutamate on a tour under the skin
Main Category: MRSA / Drug ResistanceArticle Date: 04 Feb 2005 - 15:00 PDT
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
4 (1 votes) |
The microorganism Staphylococcus epidermidis is harmless on human skin, but it is the leading cause of hospital-acquired infections and infections of indwelling medical devices. S. epidermidis is associated with an enormous number of infections in people with prosthetic joints, replacement heart valves, and intravenous catheters, and antibiotic resistance makes it tough to battle. Moreover, the mechanism through which the organism becomes so pathogenic once the protective barrier of the skin is removed remains unclear.
In their study appearing online on February 3 in advance of publication in the March 1 print edition of the Journal of Clinical Investigation,.Michael Otto and colleagues from Rocky Mountain Laboratories demonstrate that S. epidermidis secretes an extracellular polymer called poly-gamma-glutamate (PGA) to facilitate growth and ensure survival of the bacteria inside the human host. PGA protects the pathogen from innate host defenses during infection. S. epidermidis is the only human pathogen known to produce PGA other than Bacillus anthracis, but several differences exist in how the two pathogens use PGA to their advantage. PGA is currently used as an antigen for vaccine production against Anthrax
This paper presents PGA as a promising target for drug development aimed at combating these hospital-acquired infections and other illnesses caused by related bacteria.
TITLE: Key role of poly-gamma-DL-glutamate acid in immune evasion and virulence of Staphylococcus epidermidis
AUTHOR CONTACT: Michael Otto
Rocky Mountain Laboratories, National Institutes of Health, Hamilton, Montana, USA
Phone: (406) 363-9283; Fax: (406) 375-9677; E-mail: motto@niaid.nih.gov
View the PDF of this article at: www.the-jci.org/press/23523.pdf
From 5:00PM USA EST Thursday February 3, 2005 a PDF of this article will be available at: http://www.jci.org/papbyrecent.shtml
Stacie Bloom - press_releases@the-jci.org
Journal of Clinical Investigation
Visit our mrsa / drug resistance section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/19612.php>
APA
http://www.medicalnewstoday.com/releases/19612.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




